UniProt ID | KDM1A_HUMAN | |
---|---|---|
UniProt AC | O60341 | |
Protein Name | Lysine-specific histone demethylase 1A | |
Gene Name | KDM1A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 852 | |
Subcellular Localization | Nucleus . | |
Protein Description | Histone demethylase that demethylates both 'Lys-4' (H3K4me) and 'Lys-9' (H3K9me) of histone H3, thereby acting as a coactivator or a corepressor, depending on the context. Acts by oxidizing the substrate by FAD to generate the corresponding imine that is subsequently hydrolyzed. Acts as a corepressor by mediating demethylation of H3K4me, a specific tag for epigenetic transcriptional activation. Demethylates both mono- (H3K4me1) and di-methylated (H3K4me2) H3K4me. May play a role in the repression of neuronal genes. Alone, it is unable to demethylate H3K4me on nucleosomes and requires the presence of RCOR1/CoREST to achieve such activity. Also acts as a coactivator of androgen receptor (ANDR)-dependent transcription, by being recruited to ANDR target genes and mediating demethylation of H3K9me, a specific tag for epigenetic transcriptional repression. The presence of PRKCB in ANDR-containing complexes, which mediates phosphorylation of 'Thr-6' of histone H3 (H3T6ph), a specific tag that prevents demethylation H3K4me, prevents H3K4me demethylase activity of KDM1A. Demethylates di-methylated 'Lys-370' of p53/TP53 which prevents interaction of p53/TP53 with TP53BP1 and represses p53/TP53-mediated transcriptional activation. Demethylates and stabilizes the DNA methylase DNMT1. Required for gastrulation during embryogenesis. Component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development. Effector of SNAI1-mediated transcription repression of E-cadherin/CDH1, CDN7 and KRT8. Required for the maintenance of the silenced state of the SNAI1 target genes E-cadherin/CDH1 and CDN7.. | |
Protein Sequence | MLSGKKAAAAAAAAAAAATGTEAGPGTAGGSENGSEVAAQPAGLSGPAEVGPGAVGERTPRKKEPPRASPPGGLAEPPGSAGPQAGPTVVPGSATPMETGIAETPEGRRTSRRKRAKVEYREMDESLANLSEDEYYSEEERNAKAEKEKKLPPPPPQAPPEEENESEPEEPSGVEGAAFQSRLPHDRMTSQEAACFPDIISGPQQTQKVFLFIRNRTLQLWLDNPKIQLTFEATLQQLEAPYNSDTVLVHRVHSYLERHGLINFGIYKRIKPLPTKKTGKVIIIGSGVSGLAAARQLQSFGMDVTLLEARDRVGGRVATFRKGNYVADLGAMVVTGLGGNPMAVVSKQVNMELAKIKQKCPLYEANGQAVPKEKDEMVEQEFNRLLEATSYLSHQLDFNVLNNKPVSLGQALEVVIQLQEKHVKDEQIEHWKKIVKTQEELKELLNKMVNLKEKIKELHQQYKEASEVKPPRDITAEFLVKSKHRDLTALCKEYDELAETQGKLEEKLQELEANPPSDVYLSSRDRQILDWHFANLEFANATPLSTLSLKHWDQDDDFEFTGSHLTVRNGYSCVPVALAEGLDIKLNTAVRQVRYTASGCEVIAVNTRSTSQTFIYKCDAVLCTLPLGVLKQQPPAVQFVPPLPEWKTSAVQRMGFGNLNKVVLCFDRVFWDPSVNLFGHVGSTTASRGELFLFWNLYKAPILLALVAGEAAGIMENISDDVIVGRCLAILKGIFGSSAVPQPKETVVSRWRADPWARGSYSYVAAGSSGNDYDLMAQPITPGPSIPGAPQPIPRLFFAGEHTIRNYPATVHGALLSGLREAGRIADQFLGAMYTLPRQATPGVPAQQSPSM | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
19 | Phosphorylation | AAAAAAATGTEAGPG HHHHHHHHCCCCCCC | 39.65 | 27080861 | |
21 | Phosphorylation | AAAAATGTEAGPGTA HHHHHHCCCCCCCCC | 20.50 | 27080861 | |
27 | Phosphorylation | GTEAGPGTAGGSENG CCCCCCCCCCCCCCC | 25.84 | 23312004 | |
27 (in isoform 2) | Phosphorylation | - | 25.84 | 27251275 | |
31 | Phosphorylation | GPGTAGGSENGSEVA CCCCCCCCCCCCCCC | 27.28 | 23312004 | |
35 | Phosphorylation | AGGSENGSEVAAQPA CCCCCCCCCCCCCCC | 40.24 | 29496963 | |
45 | Phosphorylation | AAQPAGLSGPAEVGP CCCCCCCCCCCCCCC | 41.64 | 30278072 | |
59 | Phosphorylation | PGAVGERTPRKKEPP CCCCCCCCCCCCCCC | 24.12 | 30278072 | |
59 (in isoform 2) | Phosphorylation | - | 24.12 | 27251275 | |
69 | Phosphorylation | KKEPPRASPPGGLAE CCCCCCCCCCCCCCC | 32.67 | 29255136 | |
69 (in isoform 2) | Phosphorylation | - | 32.67 | 27251275 | |
80 | Phosphorylation | GLAEPPGSAGPQAGP CCCCCCCCCCCCCCC | 35.51 | 23401153 | |
80 (in isoform 2) | Phosphorylation | - | 35.51 | - | |
88 | Phosphorylation | AGPQAGPTVVPGSAT CCCCCCCEECCCCCC | 32.97 | 29255136 | |
88 (in isoform 2) | Phosphorylation | - | 32.97 | - | |
93 | Phosphorylation | GPTVVPGSATPMETG CCEECCCCCCCCCCC | 23.93 | 25850435 | |
95 | Phosphorylation | TVVPGSATPMETGIA EECCCCCCCCCCCCC | 25.51 | 30278072 | |
99 | Phosphorylation | GSATPMETGIAETPE CCCCCCCCCCCCCCC | 27.86 | 30576142 | |
104 | Phosphorylation | METGIAETPEGRRTS CCCCCCCCCCCCCCC | 20.02 | 25159151 | |
104 (in isoform 2) | Phosphorylation | - | 20.02 | 27251275 | |
111 | Phosphorylation | TPEGRRTSRRKRAKV CCCCCCCCHHHHHHH | 28.42 | - | |
114 | "N6,N6-dimethyllysine" | GRRTSRRKRAKVEYR CCCCCHHHHHHHHHH | 56.44 | - | |
114 | Methylation | GRRTSRRKRAKVEYR CCCCCHHHHHHHHHH | 56.44 | - | |
117 | Sumoylation | TSRRKRAKVEYREMD CCHHHHHHHHHHHHH | 39.36 | - | |
117 | Sumoylation | TSRRKRAKVEYREMD CCHHHHHHHHHHHHH | 39.36 | - | |
120 | Ubiquitination | RKRAKVEYREMDESL HHHHHHHHHHHHHHH | 18.17 | 23503661 | |
123 | Ubiquitination | AKVEYREMDESLANL HHHHHHHHHHHHHCC | 5.25 | 23503661 | |
126 | Phosphorylation | EYREMDESLANLSED HHHHHHHHHHCCCHH | 28.63 | 22167270 | |
126 (in isoform 2) | Phosphorylation | - | 28.63 | - | |
131 | Phosphorylation | DESLANLSEDEYYSE HHHHHCCCHHHHCCH | 42.69 | 22167270 | |
131 | Ubiquitination | DESLANLSEDEYYSE HHHHHCCCHHHHCCH | 42.69 | 27667366 | |
131 (in isoform 2) | Phosphorylation | - | 42.69 | 27251275 | |
135 | Phosphorylation | ANLSEDEYYSEEERN HCCCHHHHCCHHHHH | 25.31 | 22167270 | |
135 (in isoform 2) | Phosphorylation | - | 25.31 | - | |
136 | Phosphorylation | NLSEDEYYSEEERNA CCCHHHHCCHHHHHH | 13.93 | 22167270 | |
136 (in isoform 2) | Phosphorylation | - | 13.93 | - | |
137 | Phosphorylation | LSEDEYYSEEERNAK CCHHHHCCHHHHHHH | 37.32 | 22167270 | |
137 (in isoform 2) | Phosphorylation | - | 37.32 | 27251275 | |
141 | Ubiquitination | EYYSEEERNAKAEKE HHCCHHHHHHHHHHH | 52.24 | 23000965 | |
146 | Ubiquitination | EERNAKAEKEKKLPP HHHHHHHHHHCCCCC | 62.13 | 21890473 | |
151 | Ubiquitination | KAEKEKKLPPPPPQA HHHHHCCCCCCCCCC | 13.10 | 23000965 | |
155 | Ubiquitination | EKKLPPPPPQAPPEE HCCCCCCCCCCCCCC | 39.13 | 27667366 | |
166 | Phosphorylation | PPEEENESEPEEPSG CCCCCCCCCCCCCCC | 70.77 | 29255136 | |
166 (in isoform 2) | Phosphorylation | - | 70.77 | 20873877 | |
172 | Phosphorylation | ESEPEEPSGVEGAAF CCCCCCCCCCCHHHH | 59.77 | 30266825 | |
172 (in isoform 2) | Phosphorylation | - | 59.77 | 22210691 | |
181 | Phosphorylation | VEGAAFQSRLPHDRM CCHHHHHHCCCCCCC | 29.36 | 28176443 | |
182 (in isoform 2) | Phosphorylation | - | 41.26 | 25247763 | |
183 (in isoform 2) | Phosphorylation | - | 5.52 | 25247763 | |
186 (in isoform 2) | Phosphorylation | - | 39.86 | 20873877 | |
187 | Methylation | QSRLPHDRMTSQEAA HHCCCCCCCCHHHHH | 27.52 | 115482339 | |
189 | Phosphorylation | RLPHDRMTSQEAACF CCCCCCCCHHHHHCC | 28.31 | 26074081 | |
190 | Phosphorylation | LPHDRMTSQEAACFP CCCCCCCHHHHHCCH | 19.38 | 26074081 | |
192 (in isoform 2) | Phosphorylation | - | 37.69 | 20873877 | |
201 (in isoform 2) | Phosphorylation | - | 44.76 | 20873877 | |
268 | Acetylation | LINFGIYKRIKPLPT CEEEEECCCCCCCCC | 45.81 | 25953088 | |
268 | Ubiquitination | LINFGIYKRIKPLPT CEEEEECCCCCCCCC | 45.81 | 23000965 | |
271 | Ubiquitination | FGIYKRIKPLPTKKT EEECCCCCCCCCCCC | 44.53 | 23000965 | |
275 | Phosphorylation | KRIKPLPTKKTGKVI CCCCCCCCCCCCCEE | 53.51 | 22964224 | |
276 | Acetylation | RIKPLPTKKTGKVII CCCCCCCCCCCCEEE | 46.53 | 25953088 | |
276 | Ubiquitination | RIKPLPTKKTGKVII CCCCCCCCCCCCEEE | 46.53 | - | |
277 | Ubiquitination | IKPLPTKKTGKVIII CCCCCCCCCCCEEEE | 66.06 | - | |
280 | Ubiquitination | LPTKKTGKVIIIGSG CCCCCCCCEEEECCC | 35.18 | - | |
284 | Ubiquitination | KTGKVIIIGSGVSGL CCCCEEEECCCHHHH | 2.17 | 21963094 | |
288 | Ubiquitination | VIIIGSGVSGLAAAR EEEECCCHHHHHHHH | 4.37 | 23000965 | |
288 (in isoform 2) | Ubiquitination | - | 4.37 | - | |
290 | Ubiquitination | IIGSGVSGLAAARQL EECCCHHHHHHHHHH | 19.54 | 21963094 | |
291 | Ubiquitination | IGSGVSGLAAARQLQ ECCCHHHHHHHHHHH | 1.98 | 23000965 | |
299 | Phosphorylation | AAARQLQSFGMDVTL HHHHHHHHCCCCEEE | 32.15 | - | |
305 | Phosphorylation | QSFGMDVTLLEARDR HHCCCCEEEEEHHHH | 22.74 | - | |
322 | Trimethylation | GRVATFRKGNYVADL CEEEEEECCCEEEEC | 47.52 | - | |
322 | Methylation | GRVATFRKGNYVADL CEEEEEECCCEEEEC | 47.52 | - | |
322 | Ubiquitination | GRVATFRKGNYVADL CEEEEEECCCEEEEC | 47.52 | - | |
335 | Phosphorylation | DLGAMVVTGLGGNPM ECCCEEEECCCCCCH | 18.45 | - | |
346 | Phosphorylation | GNPMAVVSKQVNMEL CCCHHHEEHHHCHHH | 15.69 | - | |
346 | Ubiquitination | GNPMAVVSKQVNMEL CCCHHHEEHHHCHHH | 15.69 | 21963094 | |
347 | Ubiquitination | NPMAVVSKQVNMELA CCHHHEEHHHCHHHH | 46.81 | - | |
352 | Ubiquitination | VSKQVNMELAKIKQK EEHHHCHHHHHHHHH | 40.13 | 21963094 | |
355 | Acetylation | QVNMELAKIKQKCPL HHCHHHHHHHHHCCC | 64.16 | 25953088 | |
355 | Ubiquitination | QVNMELAKIKQKCPL HHCHHHHHHHHHCCC | 64.16 | 21906983 | |
355 (in isoform 1) | Ubiquitination | - | 64.16 | 21890473 | |
359 | Ubiquitination | ELAKIKQKCPLYEAN HHHHHHHHCCCEECC | 32.58 | 29967540 | |
363 | Phosphorylation | IKQKCPLYEANGQAV HHHHCCCEECCCCCC | 9.72 | 27642862 | |
372 | Ubiquitination | ANGQAVPKEKDEMVE CCCCCCCHHHHHHHH | 71.45 | 29967540 | |
374 | Ubiquitination | GQAVPKEKDEMVEQE CCCCCHHHHHHHHHH | 66.18 | 21906983 | |
374 (in isoform 1) | Ubiquitination | - | 66.18 | 21890473 | |
375 (in isoform 2) | Ubiquitination | - | 50.76 | 21890473 | |
377 | Sulfoxidation | VPKEKDEMVEQEFNR CCHHHHHHHHHHHHH | 6.03 | 21406390 | |
398 (in isoform 2) | Ubiquitination | - | 10.41 | 21890473 | |
421 | Ubiquitination | VVIQLQEKHVKDEQI HHHHHHHHCCCHHHH | 40.51 | 23503661 | |
424 | Sumoylation | QLQEKHVKDEQIEHW HHHHHCCCHHHHHHH | 56.09 | - | |
424 | Sumoylation | QLQEKHVKDEQIEHW HHHHHCCCHHHHHHH | 56.09 | - | |
424 | Ubiquitination | QLQEKHVKDEQIEHW HHHHHCCCHHHHHHH | 56.09 | 21906983 | |
424 (in isoform 1) | Ubiquitination | - | 56.09 | 21890473 | |
432 | Acetylation | DEQIEHWKKIVKTQE HHHHHHHHHHHHCHH | 34.23 | 7972565 | |
432 | Ubiquitination | DEQIEHWKKIVKTQE HHHHHHHHHHHHCHH | 34.23 | 21906983 | |
432 (in isoform 1) | Ubiquitination | - | 34.23 | 21890473 | |
433 | Acetylation | EQIEHWKKIVKTQEE HHHHHHHHHHHCHHH | 47.76 | 7972575 | |
433 | Ubiquitination | EQIEHWKKIVKTQEE HHHHHHHHHHHCHHH | 47.76 | - | |
436 | Acetylation | EHWKKIVKTQEELKE HHHHHHHHCHHHHHH | 48.22 | 7972585 | |
436 | Ubiquitination | EHWKKIVKTQEELKE HHHHHHHHCHHHHHH | 48.22 | 29967540 | |
441 | Ubiquitination | IVKTQEELKELLNKM HHHCHHHHHHHHHHH | 5.27 | 23503661 | |
442 | Sumoylation | VKTQEELKELLNKMV HHCHHHHHHHHHHHH | 49.98 | - | |
442 | Sumoylation | VKTQEELKELLNKMV HHCHHHHHHHHHHHH | 49.98 | 28112733 | |
442 | Ubiquitination | VKTQEELKELLNKMV HHCHHHHHHHHHHHH | 49.98 | 23000965 | |
442 (in isoform 1) | Ubiquitination | - | 49.98 | 21890473 | |
443 | Ubiquitination | KTQEELKELLNKMVN HCHHHHHHHHHHHHC | 71.73 | 23000965 | |
444 | Ubiquitination | TQEELKELLNKMVNL CHHHHHHHHHHHHCH | 6.45 | 23503661 | |
445 | Ubiquitination | QEELKELLNKMVNLK HHHHHHHHHHHHCHH | 6.41 | 23503661 | |
447 | Ubiquitination | ELKELLNKMVNLKEK HHHHHHHHHHCHHHH | 44.16 | 23000965 | |
447 (in isoform 1) | Ubiquitination | - | 44.16 | 21890473 | |
448 | Ubiquitination | LKELLNKMVNLKEKI HHHHHHHHHCHHHHH | 2.05 | 33845483 | |
448 (in isoform 2) | Ubiquitination | - | 2.05 | 21890473 | |
449 | Ubiquitination | KELLNKMVNLKEKIK HHHHHHHHCHHHHHH | 8.95 | 23000965 | |
452 | 2-Hydroxyisobutyrylation | LNKMVNLKEKIKELH HHHHHCHHHHHHHHH | 52.32 | - | |
452 | Sumoylation | LNKMVNLKEKIKELH HHHHHCHHHHHHHHH | 52.32 | - | |
452 | Ubiquitination | LNKMVNLKEKIKELH HHHHHCHHHHHHHHH | 52.32 | 23000965 | |
454 | Ubiquitination | KMVNLKEKIKELHQQ HHHCHHHHHHHHHHH | 58.45 | - | |
456 | Ubiquitination | VNLKEKIKELHQQYK HCHHHHHHHHHHHHH | 66.35 | 27667366 | |
456 (in isoform 2) | Ubiquitination | - | 66.35 | 21890473 | |
460 | Ubiquitination | EKIKELHQQYKEASE HHHHHHHHHHHHHHC | 62.01 | 29967540 | |
462 | Ubiquitination | IKELHQQYKEASEVK HHHHHHHHHHHHCCC | 12.29 | 23000965 | |
463 | Ubiquitination | KELHQQYKEASEVKP HHHHHHHHHHHCCCC | 42.33 | 32015554 | |
466 | Phosphorylation | HQQYKEASEVKPPRD HHHHHHHHCCCCCCC | 43.97 | 29116813 | |
466 | Ubiquitination | HQQYKEASEVKPPRD HHHHHHHHCCCCCCC | 43.97 | 23000965 | |
466 (in isoform 2) | Ubiquitination | - | 43.97 | 21890473 | |
467 | Ubiquitination | QQYKEASEVKPPRDI HHHHHHHCCCCCCCC | 62.70 | 21890473 | |
469 | Sumoylation | YKEASEVKPPRDITA HHHHHCCCCCCCCCH | 45.30 | 28112733 | |
469 | Ubiquitination | YKEASEVKPPRDITA HHHHHCCCCCCCCCH | 45.30 | 29967540 | |
471 | Ubiquitination | EASEVKPPRDITAEF HHHCCCCCCCCCHHH | 40.64 | 21890473 | |
471 (in isoform 2) | Ubiquitination | - | 40.64 | 21890473 | |
472 | Ubiquitination | ASEVKPPRDITAEFL HHCCCCCCCCCHHHH | 57.39 | 23000965 | |
476 | Ubiquitination | KPPRDITAEFLVKSK CCCCCCCHHHHHHCC | 13.08 | 23000965 | |
480 | Ubiquitination | DITAEFLVKSKHRDL CCCHHHHHHCCCCCH | 8.81 | 27667366 | |
481 | Ubiquitination | ITAEFLVKSKHRDLT CCHHHHHHCCCCCHH | 56.80 | 21906983 | |
481 (in isoform 1) | Ubiquitination | - | 56.80 | 21890473 | |
487 | Ubiquitination | VKSKHRDLTALCKEY HHCCCCCHHHHHHHH | 2.81 | 32015554 | |
490 (in isoform 2) | Phosphorylation | - | 3.45 | 27251275 | |
492 | Ubiquitination | RDLTALCKEYDELAE CCHHHHHHHHHHHHH | 61.22 | 29967540 | |
493 | Ubiquitination | DLTALCKEYDELAET CHHHHHHHHHHHHHH | 58.16 | 29967540 | |
503 | Acetylation | ELAETQGKLEEKLQE HHHHHHCHHHHHHHH | 42.80 | 26051181 | |
503 | Ubiquitination | ELAETQGKLEEKLQE HHHHHHCHHHHHHHH | 42.80 | PubMed | |
503 (in isoform 1) | Ubiquitination | - | 42.80 | 21890473 | |
505 | Ubiquitination | AETQGKLEEKLQELE HHHHCHHHHHHHHHH | 57.48 | 32015554 | |
505 (in isoform 2) | Ubiquitination | - | 57.48 | 21890473 | |
507 | Ubiquitination | TQGKLEEKLQELEAN HHCHHHHHHHHHHHC | 46.20 | 29967540 | |
516 | Ubiquitination | QELEANPPSDVYLSS HHHHHCCCCCEECCH | 42.86 | 29967540 | |
527 | Ubiquitination | YLSSRDRQILDWHFA ECCHHHHHHHEEECC | 44.90 | 29967540 | |
527 (in isoform 2) | Ubiquitination | - | 44.90 | 21890473 | |
531 | Ubiquitination | RDRQILDWHFANLEF HHHHHHEEECCCCEE | 5.76 | 29967540 | |
585 | Sumoylation | LAEGLDIKLNTAVRQ HHCCCCEECCHHHHH | 35.04 | - | |
585 | Ubiquitination | LAEGLDIKLNTAVRQ HHCCCCEECCHHHHH | 35.04 | 21963094 | |
588 | Phosphorylation | GLDIKLNTAVRQVRY CCCEECCHHHHHHEE | 36.65 | - | |
591 | Ubiquitination | IKLNTAVRQVRYTAS EECCHHHHHHEECCC | 27.15 | 21963094 | |
605 | Ubiquitination | SGCEVIAVNTRSTSQ CCCEEEEEECCCCCC | 5.30 | 21963094 | |
609 | Ubiquitination | VIAVNTRSTSQTFIY EEEEECCCCCCCEEE | 30.30 | 21963094 | |
611 | Phosphorylation | AVNTRSTSQTFIYKC EEECCCCCCCEEEEC | 28.59 | 23917254 | |
611 | Ubiquitination | AVNTRSTSQTFIYKC EEECCCCCCCEEEEC | 28.59 | 21963094 | |
617 | Ubiquitination | TSQTFIYKCDAVLCT CCCCEEEECCEEEEC | 22.33 | - | |
631 | Ubiquitination | TLPLGVLKQQPPAVQ CCCCCHHCCCCCCCE | 44.47 | - | |
647 | Ubiquitination | VPPLPEWKTSAVQRM CCCCCCCCCHHHHHC | 30.82 | 21906983 | |
647 (in isoform 1) | Ubiquitination | - | 30.82 | 21890473 | |
653 | Ubiquitination | WKTSAVQRMGFGNLN CCCHHHHHCCCCCCC | 22.16 | 21963094 | |
661 | Ubiquitination | MGFGNLNKVVLCFDR CCCCCCCCEEEEEEE | 36.57 | - | |
667 | Ubiquitination | NKVVLCFDRVFWDPS CCEEEEEEEEECCCC | 44.85 | 21963094 | |
671 | Ubiquitination | LCFDRVFWDPSVNLF EEEEEEECCCCCCEE | 17.47 | 21963094 | |
671 (in isoform 2) | Ubiquitination | - | 17.47 | 21890473 | |
673 | Ubiquitination | FDRVFWDPSVNLFGH EEEEECCCCCCEECC | 30.67 | 21963094 | |
683 | Phosphorylation | NLFGHVGSTTASRGE CEECCCCCCCCCCCC | 22.84 | - | |
687 | Phosphorylation | HVGSTTASRGELFLF CCCCCCCCCCCEEHH | 38.43 | - | |
732 | Acetylation | GRCLAILKGIFGSSA HHHHHHHHHHHCCCC | 43.79 | 26051181 | |
732 | Ubiquitination | GRCLAILKGIFGSSA HHHHHHHHHHHCCCC | 43.79 | - | |
744 | Ubiquitination | SSAVPQPKETVVSRW CCCCCCCCCCEEEEE | 61.85 | 23000965 | |
744 (in isoform 1) | Ubiquitination | - | 61.85 | 21890473 | |
746 | Phosphorylation | AVPQPKETVVSRWRA CCCCCCCCEEEEEEC | 32.13 | 20068231 | |
750 | Ubiquitination | PKETVVSRWRADPWA CCCCEEEEEECCCCC | 18.45 | 23000965 | |
764 | Ubiquitination | ARGSYSYVAAGSSGN CCCCEEEEECCCCCC | 2.12 | 23000965 | |
768 | Ubiquitination | YSYVAAGSSGNDYDL EEEEECCCCCCCCCC | 30.28 | 23000965 | |
768 (in isoform 2) | Ubiquitination | - | 30.28 | 21890473 | |
770 | Ubiquitination | YVAAGSSGNDYDLMA EEECCCCCCCCCCCC | 32.50 | 23000965 | |
807 | Phosphorylation | GEHTIRNYPATVHGA CCCCHHCCCHHHHHH | 5.61 | 28152594 | |
810 | Phosphorylation | TIRNYPATVHGALLS CHHCCCHHHHHHHHH | 14.45 | 28152594 | |
817 | Phosphorylation | TVHGALLSGLREAGR HHHHHHHHHHHHHHH | 36.31 | 24719451 | |
834 | Phosphorylation | DQFLGAMYTLPRQAT HHHHHHHHCCCCCCC | 12.46 | 26074081 | |
835 | Phosphorylation | QFLGAMYTLPRQATP HHHHHHHCCCCCCCC | 19.73 | 26074081 | |
838 | Methylation | GAMYTLPRQATPGVP HHHHCCCCCCCCCCC | 41.71 | 97816407 | |
841 | Phosphorylation | YTLPRQATPGVPAQQ HCCCCCCCCCCCCCC | 16.55 | 28348404 | |
849 | Phosphorylation | PGVPAQQSPSM---- CCCCCCCCCCC---- | 13.58 | 25159151 | |
851 | Phosphorylation | VPAQQSPSM------ CCCCCCCCC------ | 42.23 | 30266825 | |
873 (in isoform 2) | Phosphorylation | - | 27251275 | ||
875 (in isoform 2) | Phosphorylation | - | 27251275 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
126 | S | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
131 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
137 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
683 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
687 | S | Phosphorylation | Kinase | CSNK1A1 | P48729 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KDM1A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KDM1A_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-104; SER-131; SER-137AND SER-166, AND MASS SPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131 AND SER-137, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80; THR-104; SER-126;SER-131; SER-137; SER-166 AND SER-849, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131 AND SER-137, ANDMASS SPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166, AND MASSSPECTROMETRY. |